How Biden is battling Omicron’s rise

From: POLITICO Pulse - Thursday Dec 02,2021 03:02 pm
Presented by PhRMA: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Dec 02, 2021 View in browser
 
POLITICO's Pulse newsletter logo

By Adam Cancryn and Sarah Owermohle

Presented by

PhRMA

With Alice Miranda Ollstein

Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our s each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro.

Quick Fix

— Health officials are bracing for more cases of the Omicron Covid-19 variant after confirming the first U.S. infection in California.

— The White House is out with a plan redoubling efforts to combat Covid-19, including an initiative that could make testing far more affordable.

— Senate Republican leaders are trying to tamp down threats of a government shutdown over the Biden administration’s vaccine mandates.

WELCOME TO THURSDAY PULSE — and don't miss this must read on Fauci's falling out with Fox, co-bylined by a moonlighting PULSE author. Send tips to acancryn@politico.com and sowermohle@politico.com.

 

A message from PhRMA:

At a time when the science has never been more promising, the Democrats’ latest drug pricing scheme puts patients in harm’s way by threatening future treatments and cures. Learn more.

 
Driving the Day

OMICRON ARRIVES — The newest variant of Covid-19 has officially made it to U.S. shores. The next question the Biden administration is racing to answer is how many cases have already spread throughout the country.

Health officials are on the hunt for more instances of the Omicron variant after the CDC confirmed the first case Wednesday in California — a discovery officials said was both inevitable and further evidence of the need to get more Americans vaccinated, POLITICO’s Erin Banco, David Lim and Adam report.

Biden health officials are already evaluating several other potential Omicron cases, according to three people with knowledge of the matter. And the CDC is planning to issue new guidance to states for contact tracing and reporting the variant’s anticipated rise.

What we know: The first reported Omicron infection is in an individual who traveled back from South Africa in late November. The person was vaccinated but has not yet received a booster. They began experiencing symptoms within days of arriving home and are now self-quarantining. All close contacts have been contacted and have tested negative.

But if there’s one confirmed case, there are almost assuredly many more that haven’t yet been detected. And dozens have already been reported across Europe, Asia and Africa.

What we don’t know: How serious of a threat this will be. Definitive data on Omicron is still at least a couple weeks away, and it’s unclear whether the variant is more virulent, more contagious or better at evading the vaccines than previous versions.

Biden officials in the meantime are ramping up efforts to get booster shots to more Americans, arguing that it will provide significantly more protection no matter how effective the current vaccines are at fighting off Omicron.

One thing to keep an eye on: Anthony Fauci, Biden’s chief medical adviser, wouldn’t rule out a change to the government’s definition of full vaccination to include a booster.

“It could change,” he said. “We don’t know right now that it should change, but it might.”

HOW BIDEN IS FIGHTING BACK — The White House is rolling out a new slate of initiatives aimed at ramping up Covid-19 vaccinations and slowing the virus’ spread in a desperate bid to avoid a winter surge.

The wide-ranging strategy President Joe Biden will detail this afternoon largely builds on infrastructure set up over the last several months to accelerate vaccine distribution and encourage more people to get initial doses and booster shots.

But it does include a few brand new policies. Insurers will be required to cover the cost of at-home Covid-19 tests under new guidance that the administration plans to issue in January. That could make it more affordable for roughly 150 million Americans to test themselves more often.

Still, there are unknowns, such as how easy it will be to get reimbursed and whether enough tests will be available to meet demand.

Medicaid will also pay providers for vaccine counseling. The government will cover all counseling visits for most children up to age 21.

And the White House has vowed to accelerate delivery of 200 million doses abroad over the next 100 days — nearly doubling the amount the U.S. has sent abroad so far.

Expect another big messaging blitz, too. The administration is backing a series of public education campaigns and pledging to expand existing efforts to make it easier to get shots in arms.

The lingering question: Will it be enough to avoid a resurgence? Health officials all agree the best way to end the pandemic is to get more unvaccinated people vaccinated. But despite making vaccines free and widely available, as much as a fifth of the country is dead set against them — and there’s little evidence the federal government is going to be able to change most of their minds.

 

DON’T MISS CONGRESS MINUTES: Need to follow the action on Capitol Hill blow-by-blow? Check out Minutes, POLITICO’s new platform that delivers the latest exclusives, twists and much more in real time. Get it on your desktop or download the POLITICO mobile app for iOS or Android. CHECK OUT CONGRESS MINUTES HERE.

 
 


In Congress

GOP WEIGHS SHUTTERING GOVERNMENT OVER VAX MANDATESSenate Minority Leader Mitch McConnell has vowed not to shut down the government or breach the debt ceiling. But a vocal faction within his own party has other ideas , POLITICO’s Burgess Everett reports.

Conservatives led by Sen. Mike Lee (R-Utah) want to make government funding contingent on the Biden administration defunding its own Covid vaccine mandate — a demand that would put Congress on course for a shutdown at the end of the week.

The group in favor of the move is small and includes Sens. Ted Cruz (R-Texas), Ron Johnson (R-Wis.) and Roger Marshall (R-Kan.). But they are dug in, making this the latest test of whether McConnell can keep his conference together in time to avoid catastrophe.

Biden isn’t likely to back off his mandate strategy, and even other Republicans are pleading for a less confrontational approach. Options include holding a separate vote on the mandates next week or making the mandate rollback an amendment vote.

But Lee has argued that defunding the mandate through the spending bill is the most effective way, meaning McConnell and his leadership team will need to find a path that convinces enough Republicans to back away from a funding fight and agree to keep the government open.

Meanwhile: The House is still seeking a stopgap deal. A plan to reach a bipartisan agreement by Wednesday morning never materialized, leaving lawmakers scrambling to finalize a funding measure in time to avert even a brief shutdown, POLITICO’s Sarah Ferris and Caitlin Emma report.

Among the sticking points: How long the funding should last. Democrats have pushed for an extension through late January. But Republicans want a longer timeline, in hopes of keeping the government at Trump-era spending levels for an extended period.

 

A message from PhRMA:

Advertisement Image

 
Supreme Court

SCOTUS WRESTLES WITH FATE OF ROE V. WADEThe outcome of the Supreme Court case on Mississippi’s 15-week abortion ban could determine the fate of Roe v. Wade — but also impact precedents that range far beyond abortion , POLITICO’s Alice Miranda Ollstein and Josh Gerstein report. Here’s what you need to know from Wednesday’s arguments:

— John Roberts wants a compromise, but he’s yet to find any takers. The chief justice suggested the court could uphold Mississippi’s ban without completely overturning Roe v. Wade — an idea that didn’t seem to gain much traction with the other justices or lawyers on either side.

— Does it matter if times have changed for women? Mississippi and some conservative justices argued so much has changed since Roe v. Wade that abortion is no longer necessary. The court’s left and lawyers for abortion clinics countered that the core question of a person’s right to decide whether to terminate a pregnancy hasn’t changed.

— What else is on the chopping block if Roe falls? Abortion rights groups are warned that overturning Roe would open the door to reversing other major decisions, including those on marriage equality and contraception. But Mississippi tried to shut down those fears by contending abortion is different than any other right.

— How will the court’s decision impact public opinion? Justices across the spectrum argued the case’s outcome could further perception that the court is politically motivated, with liberals saying ignoring abortion precedent would severely damage its standing. Conservative justices maintained the best way to preserve credibility would be to return the issue to the states.

— Overturning Roe would only intensify the abortion wars. Advocates on both sides of the issue made clear they’ll continue to fight at all levels if Mississippi’s ban is upheld or Roe is overturned, contrary to the state’s argument that a decision in its favor would tamp down fights over the procedure.

 

BECOME A GLOBAL INSIDER: The world is more connected than ever. It has never been more essential to identify, unpack and analyze important news, trends and decisions shaping our future — and we’ve got you covered! Every Monday, Wednesday and Friday, Global Insider author Ryan Heath navigates the global news maze and connects you to power players and events changing our world. Don’t miss out on this influential global community. Subscribe now.

 
 


Vaccines

KFF: BOOSTER SHOTS SOAR, BUT VAX OPTIMISM WANES — Nearly a quarter of American adults have gotten their Covid-19 booster shot, a proportion that’s up sharply from October, according to new survey data from the Kaiser Family Foundation.

Another 37 percent of adults said they will “definitely” seek a booster, amid a Biden administration blitz last month to encourage people to seek additional protection from the virus.

That compares to October when just 10 percent reported receiving a booster — with another 43 percent saying they’d “definitely” get it.

So far, enthusiasm for booster shots is also holding across demographic and political lines, KFF found: More than half of adults in every racial and ethnic, age and political group said they already have or will likely get a booster once they’re eligible.

There’s still significant resistance, though. Nearly 20 percent of adults overall said they probably or will definitely not get a booster, including 31 percent of Republicans.

And there’s little indication that attitudes are changing for those who remain completely unvaccinated. Roughly 73 percent said they’ve gotten an initial vaccine dose, compared with 72 percent in September.

Americans’ optimism, meanwhile, is fading. Even before the Omicron variant showed up, people were becoming increasingly disheartened over the pace of vaccinations. Fifty-eight percent reported feeling “frustrated” with the vaccination campaign, up from 50 percent in January.

The share of Americans who feel optimistic has also fallen, from 66 percent in January to 48 percent.

Names in the News

Hannah Wesolowski is the new national director of government relations, policy and advocacy at the National Alliance on Mental Illness. She was previously NAMI’s director of field advocacy.

The National Institute for Health Care Management Foundation elected Curtis Barnett the chair of its board of directors. Barnett is the president and CEO of Arkansas Blue Cross and Blue Shield.

What We're Reading

A federal appeals court rejected Moderna’s bid to overturn key patents tied to the delivery vehicle for its Covid-19 vaccine, Endpoints News’ Zachary Brennan reports.

The Omicron variant’s emergence emphasizes the need for better worldwide genomic surveillance, Vox’s Umair Irfan writes.

As the Supreme Court considers a case that could overturn Roe v. Wade, Sen. Susan Collins (R-Maine) now favors passing legislation to enshrine Roe’s protections, NBC News’ Sahil Kapur reports.

 

A message from PhRMA:

The Democrats’ hyper-partisan drug pricing plan is a detriment to patients and the future of medical research.

The plan guts the very incentives necessary to encourage investment in further research and development after medicines are approved, giving the government the power to pick winners and losers for lifesaving medicines.

While some would have you believe this is “negotiation,” it isn’t. It’s government price setting that does little to address patient affordability and will decimate the competitive ecosystem in the United States that has brought hope to so many Americans in the form of new medical advances where before there were none. No matter what they call it, this plan will result in the same outcome: negative consequences for the patients with the most need. Read more.

 
 

Follow us on Twitter

Adriel Bettelheim @abettel

Sara Smith @sarasmarley

Adam Cancryn @adamcancryn

Tucker Doherty @tucker_doherty

Dan Goldberg @dancgoldberg

David Lim @davidalim

Alice Miranda Ollstein @aliceollstein

Sarah Owermohle @owermohle

Carmen Paun @carmenpaun

Darius Tahir @dariustahir

Erin Banco @ErinBanco

Lauren Gardner @Gardner_LM

Katherine Ellen Foley @katherineefoley

Ben Leonard @_BenLeonard_

Megan R. Wilson @misswilson

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Pulse